Silji Abraham West Pharmaceutical Services Inc (WST) insider trading activity

Silji Abraham is SVP, Chief Technology Officer of WEST PHARMACEUTICAL SERVICES INC. Currently has a direct ownership of 3,138 shares of WST, which is worth approximately $1.04 Million. The most recent transaction as insider was on Oct 29, 2024, when has been sold 180 shares (Common Stock) at a price of $318.41 per share, resulting in proceeds of $57,313. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.14K

9.72% 3M change

25.45% 12M change

Total Value Held $1.04 Million

Silji Abraham Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 29 2024	SELL Payment of exercise price or tax liability	$57,313 $318.41 p/Share	180 Reduced 5.42%	3,138 Common Stock
Oct 29 2024	BUY Exercise of conversion of derivative security	-	458 Added 12.13%	3,318 Common Stock
Jun 12 2024	SELL Open market or private sale	$595,404 $330.78 p/Share	1,800 Reduced 38.63%	2,860 Common Stock
Feb 23 2024	SELL Open market or private sale	$2,559,380 $365.0 p/Share	7,012 Reduced 60.08%	4,660 Common Stock
Feb 23 2024	BUY Exercise of conversion of derivative security	$1,214,618 $173.22 p/Share	7,012 Added 37.53%	11,672 Common Stock
Feb 20 2024	BUY Grant, award, or other acquisition	-	646 Added 12.17%	4,660 Common Stock
Aug 08 2023	SELL Open market or private sale	$3,243,028 $397.43 p/Share	8,160 Reduced 65.97%	4,209 Common Stock
Aug 08 2023	BUY Exercise of conversion of derivative security	$836,481 $102.51 p/Share	8,160 Added 39.75%	12,369 Common Stock
May 01 2023	SELL Open market or private sale	$2,934,117 $365.85 p/Share	8,020 Reduced 65.58%	4,209 Common Stock
May 01 2023	BUY Exercise of conversion of derivative security	$691,644 $86.24 p/Share	8,020 Added 39.61%	12,229 Common Stock
Mar 09 2023	SELL Open market or private sale	$483,855 $322.57 p/Share	1,500 Reduced 26.27%	4,209 Common Stock
Mar 01 2023	BUY Grant, award, or other acquisition	$74,477 $318.28 p/Share	234 Added 3.94%	5,709 Common Stock
Feb 21 2023	BUY Grant, award, or other acquisition	$697,390 $306.68 p/Share	2,274 Added 29.35%	5,475 Common Stock
Aug 01 2022	SELL Open market or private sale	$1,848,280 $343.93 p/Share	5,374 Reduced 62.67%	3,201 Common Stock
Feb 22 2022	BUY Grant, award, or other acquisition	$922,087 $369.13 p/Share	2,498 Added 22.56%	8,575 Common Stock
May 10 2021	SELL Open market or private sale	$727,285 $335.0 p/Share	2,171 Reduced 26.32%	6,077 Common Stock
Feb 26 2021	SELL Payment of exercise price or tax liability	$190,000 $280.65 p/Share	677 Reduced 7.59%	8,248 Common Stock
Feb 22 2021	BUY Grant, award, or other acquisition	$702,619 $272.65 p/Share	2,577 Added 22.4%	8,925 Common Stock
Oct 29 2020	BUY Grant, award, or other acquisition	-	454 Added 6.67%	6,348 Common Stock

Silji Abraham

SVP, Chief Technology Officer

Exton,

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells WST shares.

Notify only if

Value

Insider Trading

Get notified when an West Pharmaceutical Services Inc insider buys or sells WST shares.

Notify only if

Operation

Value

Type

News

Receive news related to WEST PHARMACEUTICAL SERVICES INC

Track Activities on WST

Account